BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q4 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,322,132 | -8.7% | 1,094,916 | +10.3% | 0.03% | +12.5% |
| Q2 2023 | $45,242,630 | -16.1% | 993,034 | -25.3% | 0.02% | -20.0% |
| Q1 2023 | $53,901,482 | -27.1% | 1,328,932 | -8.4% | 0.03% | -30.2% |
| Q4 2022 | $73,929,690 | -14.7% | 1,450,455 | -9.9% | 0.04% | -17.3% |
| Q3 2022 | $86,699,000 | +10.6% | 1,609,694 | +31.9% | 0.05% | +18.2% |
| Q2 2022 | $78,381,000 | -8.8% | 1,220,345 | +10.1% | 0.04% | +10.0% |
| Q1 2022 | $85,943,000 | -37.4% | 1,108,349 | -30.7% | 0.04% | -35.5% |
| Q4 2021 | $137,317,000 | +51.9% | 1,599,694 | +42.3% | 0.06% | +44.2% |
| Q3 2021 | $90,401,000 | -17.4% | 1,123,970 | -17.3% | 0.04% | -18.9% |
| Q2 2021 | $109,423,000 | +15.7% | 1,359,269 | +21.2% | 0.05% | +3.9% |
| Q1 2021 | $94,613,000 | +12.2% | 1,121,812 | +6.7% | 0.05% | 0.0% |
| Q4 2020 | $84,338,000 | -19.3% | 1,051,074 | -19.1% | 0.05% | -29.2% |
| Q3 2020 | $104,531,000 | -16.6% | 1,299,775 | -10.7% | 0.07% | -24.2% |
| Q2 2020 | $125,282,000 | +29.3% | 1,455,069 | +21.9% | 0.10% | +9.2% |
| Q1 2020 | $96,892,000 | -13.0% | 1,193,408 | -10.4% | 0.09% | +19.2% |
| Q4 2019 | $111,396,000 | -5.7% | 1,332,289 | -1.3% | 0.07% | -11.0% |
| Q3 2019 | $118,093,000 | -39.5% | 1,350,207 | -43.3% | 0.08% | -28.7% |
| Q2 2019 | $195,182,000 | +26.1% | 2,383,302 | +25.2% | 0.12% | +25.0% |
| Q1 2019 | $154,723,000 | +16.0% | 1,902,954 | -6.1% | 0.09% | -3.2% |
| Q4 2018 | $133,350,000 | -43.4% | 2,026,096 | -33.7% | 0.10% | +37.7% |
| Q3 2018 | $235,464,000 | -38.8% | 3,054,484 | -41.4% | 0.07% | -36.7% |
| Q2 2018 | $384,671,000 | +140.3% | 5,209,585 | +111.6% | 0.11% | +43.4% |
| Q1 2018 | $160,096,000 | +55.4% | 2,461,615 | +54.4% | 0.08% | +15.2% |
| Q4 2017 | $103,041,000 | +73.1% | 1,594,169 | +68.1% | 0.07% | +61.0% |
| Q3 2017 | $59,518,000 | -21.7% | 948,576 | -24.4% | 0.04% | -24.1% |
| Q2 2017 | $75,997,000 | -19.9% | 1,255,376 | -31.4% | 0.05% | -22.9% |
| Q1 2017 | $94,833,000 | +114.4% | 1,828,747 | +83.3% | 0.07% | +94.4% |
| Q4 2016 | $44,227,000 | -54.5% | 997,571 | -51.2% | 0.04% | -47.8% |
| Q3 2016 | $97,208,000 | -2.7% | 2,042,266 | -7.6% | 0.07% | -2.8% |
| Q2 2016 | $99,932,000 | +55.5% | 2,210,044 | +41.3% | 0.07% | +47.9% |
| Q1 2016 | $64,268,000 | -5.8% | 1,564,524 | -12.5% | 0.05% | +2.1% |
| Q4 2015 | $68,236,000 | -43.5% | 1,788,742 | -51.3% | 0.05% | -49.5% |
| Q3 2015 | $120,711,000 | -78.3% | 3,674,891 | -53.7% | 0.09% | -73.7% |
| Q2 2015 | $555,316,000 | -5.7% | 7,941,111 | -7.6% | 0.35% | -3.3% |
| Q1 2015 | $588,574,000 | +3.9% | 8,592,407 | +11.2% | 0.37% | +4.9% |
| Q4 2014 | $566,467,000 | -3.2% | 7,729,206 | -5.2% | 0.35% | -3.9% |
| Q3 2014 | $585,144,000 | +43.3% | 8,153,121 | +44.3% | 0.36% | +31.0% |
| Q2 2014 | $408,382,000 | -3.7% | 5,648,543 | -2.1% | 0.28% | -8.0% |
| Q1 2014 | $424,232,000 | +25.2% | 5,769,261 | +18.3% | 0.30% | +23.4% |
| Q4 2013 | $338,909,000 | +95.4% | 4,876,463 | +84.7% | 0.24% | +90.6% |
| Q3 2013 | $173,431,000 | – | 2,640,472 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |